Druggable Biomarkers Altered in Clear Cell Renal Cell Carcinoma: Strategy for the Development of Mechanism-Based Combination Therapy

Targeted therapeutics made significant advances in the treatment of patients with advanced clear cell renal cell carcinoma (ccRCC). Resistance and serious adverse events associated with standard therapy of patients with advanced ccRCC highlight the need to identify alternative ‘druggable’ targets to...

Descripción completa

Detalles Bibliográficos
Autores principales: Rustum, Youcef M., Reis, Ryan, Rustum, Tara M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864911/
https://www.ncbi.nlm.nih.gov/pubmed/36674417
http://dx.doi.org/10.3390/ijms24020902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864911/
https://www.ncbi.nlm.nih.gov/pubmed/36674417
http://dx.doi.org/10.3390/ijms24020902

Ejemplares similares